The company that is promoting this false advertising is Atossa Genetics. Atossa Genetics was issued a warning by the FDA that their test test was misbranded in that its labeling was false or misleading and asking them to address the violation. Atossa Genetics voluntary recalled the ForeCYTE Breast Health Test from the market in October 2013.
In its advertising Atossa Genetics falsely claimed that the test was “literally a Pap smear for breast cancer.”
The FDA recommends that all women who only did a nipple aspirate test for breast cancer should get a mammogram as soon as possible